FBN2 Gene - Fibrillin 2

Genetic and clinical significance of FBN2 in connective tissue disorders

Gene Information Card

Symbol FBN2
Full Name Fibrillin 2
Gene Type Protein coding
Chromosomal Location 5q23.3
NCBI Gene ID 2201 ncbi.nlm.nih.gov/gene/2201
Ensembl ID ENSG00000138829
UniProt ID P35556
OMIM ID 121050
HGNC ID 3604
Aliases CCA, DA9, MFS2, FBNL, MASS, MFS2-like

Description

FBN2 encodes fibrillin-2, a large extracellular matrix glycoprotein that is a major component of microfibrils. These microfibrils provide structural support in connective tissues and regulate TGF-β signaling. Mutations in FBN2 cause congenital contractural arachnodactyly (Beals syndrome), a disorder characterized by joint contractures, arachnodactyly, and scoliosis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Congenital contractural arachnodactyly (Beals syndrome) Missense or splice-site mutations in FBN2 disrupt microfibril assembly and TGF-β sequestration, leading to connective tissue fragility and abnormal joint development. ClinVar, OMIM
Marfan syndrome (atypical) Rare FBN2 mutations have been reported in patients with Marfan-like features, though classic Marfan is primarily linked to FBN1. OMIM, NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Lung 12.5 Medium
Heart 8.3 Low
Skeletal muscle 6.7 Low
Skin 15.2 Medium
Aorta 18.9 High
Cell Line Expression
Cell Line nTPM Notes
Fibroblasts (skin) 22.1 High expression in dermal fibroblasts
Aortic smooth muscle cells 14.3 Moderate expression
Lung epithelial cells (A549) 9.8 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.266G>A (p.Cys89Tyr) Missense Rare Disrupts disulfide bond in EGF-like domain, impairing microfibril assembly
c.3463G>T (p.Gly1155Cys) Missense Rare Alters calcium-binding EGF domain, leading to dominant-negative effect
c.4777-2A>G Splice site Rare Exon skipping, frameshift, and premature truncation
Mutation functional classification

Loss of Function (LOF)

Rare; nonsense or frameshift mutations leading to haploinsufficiency may contribute to mild phenotypes.

Gain of Function (GOF)

Not well documented for FBN2; most mutations are dominant-negative.

Dominant Negative (DN)

Common mechanism; missense mutations in EGF-like domains produce abnormal fibrillin-2 that disrupts microfibril formation.

Pathways

ECM-receptor interaction (KEGG hsa04512)
Focal adhesion (KEGG hsa04510)
TGF-beta signaling pathway (KEGG hsa04350)
Microfibril assembly (Reactome R-HSA-216083)

Protein Summary

Fibrillin-2 is a 2912-amino acid glycoprotein with multiple calcium-binding EGF-like domains and TGF-β-binding protein-like domains. It assembles into microfibrils that provide tensile strength and elasticity in connective tissues. Fibrillin-2 also sequesters latent TGF-β complexes, regulating growth factor availability. Mutations in FBN2 primarily cause dominant-negative disruption of microfibril structure, leading to congenital contractural arachnodactyly.

Related Products

Product name Cat.No. Species Gene ID
FBN2 Knockout HEK293 Cell Line EDJ-KQ2572 Human 2201 Details Get a Quote
FBN2 Knockout A-549 Cell Line EDJ-KQ23253 Human 2201 Details Get a Quote
FBN2 Knockout HeLa Cell Line EDJ-KQ23254 Human 2201 Details Get a Quote
FBN2 Knockout HCT 116 Cell Line EDJ-KQ70166 Human 2201 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: